Application Nr Approved Date Route Status External Links
NDA022165 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Cambia Is Indicated For The Acute Treatment Of Migraine Attacks With Or Without Aura In Adults (18 Years Of Age Or Older). Limitations Of Use: Cambia Is Not Indicated For The Prophylactic Therapy Of Migraine. The Safety And Effectiveness Of Cambia Have Not Been Established For Cluster Headache, Which Is Present In An Older, Predominantly Male Population. Cambia Is A Non-Steroidal Anti-Inflammatory Drug (Nsaid) Indicated For The Acute Treatment Of Migraine Attacks With Or Without Aura In Adults 18 Years Of Age Or Older ( 1 ) Limitations Of Use ( 1 ): Cambia Is Not Indicated For The Prophylactic Therapy Of Migraine Safety And Effectiveness Of Cambia Not Established For Cluster Headache, Which Is Present In An Older, Predominantly Male Population

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Diclofenac Potassium DICLOFENAC POTASSIUM ZINC1281

Comments